Macrophage LGR4-mediated signaling promotes cellular inflammation and exacerbates atherosclerosis 3882

Abstract Description Macrophages (M?s) play a key role in both initiation and progression of atherosclerosis. A recent study reported that leucine-rich repeat-containing G protein-coupled receptor (LGR) 4 regulates the proinflammatory phenotype of cardiac M?s. Our preliminary experiments demonstrated increased expression of LGR4 in human atherosclerotic aortic segments, identified Lgr4 as the major LGR isoform in primary murine M?s, and atherogenic oxLDL stimulated LGR4 expression in M?s. However, the role of M? LGR4 in atherogenesis remains unknown. We generated novel myeloid cell-specific Lgr4 knockout mice (Lgr4ΔM) by crossing Lgr4f/f and LysM Cre mice. AAV8-hPCSK9-injected Lgr4ΔM and control Lgr4fl/fl were fed a Western diet to investigate atherosclerosis. Male Lgr4ΔM mice exhibited reduced atherosclerosis and smaller necrotic cores compared with sex-matched Lgr4fl/fl controls, without any changes in circulating monocyte frequencies. Additionally, male Lgr4ΔM mice had decreased fat mass and blood glucose levels. Interestingly, no differences were observed among female mice. Further studies revealed reduced lipid accumulation, enhanced efferocytic capacity, a suppressed M1/M2 M? ratio, and attenuated expression of different LDL-uptake genes in Lgr4ΔM M?s. Moreover, Lgr4-deficient M?s showed diminished oxLDL uptake. Altogether, these findings suggest that myeloid cell Lgr4 contributes to atherosclerotic lesion formation and identify Lgr4 as a novel therapeutic target. Funding Sources This work was supported by the National Institutes of Health grants (K99HL146954 and 530 R00HL146954) and the UTHSC College of Pharmacy Research Seed Grant. Topic Categories Immune Mechanisms of Human Disease (HUM)

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2025-11-01
DOI
https://doi.org/10.1093/jimmun/vkaf283.1630
Primary Topic
Immune cells in cancer
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Macrophage LGR4-mediated signaling promotes cellular inflammation and exacerbates atherosclerosis 3882

Malvin Ofosu‐Boateng, Bhupesh Singla, Naveed Pervaiz, Ravi Varma Aithabathula et al.
The Journal of Immunology
Immune cells in cancer
article

Macrophage LGR4-mediated signaling promotes cellular inflammation and exacerbates atherosclerosis 3882

Malvin Ofosu‐Boateng, Bhupesh Singla, Naveed Pervaiz, Ravi Varma Aithabathula, Ishita Kathuria, Udai P. Singh, Maxwell A. Gyamfi
article en

Abstract

Abstract Description Macrophages (M?s) play a key role in both initiation and progression of atherosclerosis. A recent study reported that leucine-rich repeat-containing G protein-coupled receptor (LGR) 4 regulates the proinflammatory phenotype of cardiac M?s. Our preliminary experiments demonstrated increased expression of LGR4 in human atherosclerotic aortic segments, identified Lgr4 as the major LGR isoform in primary murine M?s, and atherogenic oxLDL stimulated LGR4 expression in M?s. However, the role of M? LGR4 in atherogenesis remains unknown. We generated novel myeloid cell-specific Lgr4 knockout mice (Lgr4ΔM) by crossing Lgr4f/f and LysM Cre mice. AAV8-hPCSK9-injected Lgr4ΔM and control Lgr4fl/fl were fed a Western diet to investigate atherosclerosis. Male Lgr4ΔM mice exhibited reduced atherosclerosis and smaller necrotic cores compared with sex-matched Lgr4fl/fl controls, without any changes in circulating monocyte frequencies. Additionally, male Lgr4ΔM mice had decreased fat mass and blood glucose levels. Interestingly, no differences were observed among female mice. Further studies revealed reduced lipid accumulation, enhanced efferocytic capacity, a suppressed M1/M2 M? ratio, and attenuated expression of different LDL-uptake genes in Lgr4ΔM M?s. Moreover, Lgr4-deficient M?s showed diminished oxLDL uptake. Altogether, these findings suggest that myeloid cell Lgr4 contributes to atherosclerotic lesion formation and identify Lgr4 as a novel therapeutic target. Funding Sources This work was supported by the National Institutes of Health grants (K99HL146954 and 530 R00HL146954) and the UTHSC College of Pharmacy Research Seed Grant. Topic Categories Immune Mechanisms of Human Disease (HUM)

The Journal of ImmunologyVol. 214(Supplement_1)
University of Tennessee Health Science Center (US)
National Institutes of Health
Openalex Percentile: Top 61%
Immune cells in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.